MAI Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-300
| Closed | -$912 | – | 3439 |
|
|
2024
Q4 | $912 | Buy |
+300
| New | +$912 | ﹤0.01% | 3042 |
|
|
2023
Q2 | – | Sell |
-11,788
| Closed | -$380K | – | 1100 |
|
|
2023
Q1 | $380K | Buy |
11,788
+79
| +0.7% | +$2.55K | 0.01% | 706 |
|
|
2022
Q4 | $216K | Hold |
11,709
| – | – | ﹤0.01% | 863 |
|
|
2022
Q3 | $316K | Sell |
11,709
-89
| -0.8% | -$2.4K | 0.01% | 662 |
|
|
2022
Q2 | $163K | Hold |
11,798
| – | – | ﹤0.01% | 775 |
|
|
2022
Q1 | $230K | Hold |
11,798
| – | – | ﹤0.01% | 757 |
|
|
2021
Q4 | $193K | Buy |
+11,798
| New | +$193K | ﹤0.01% | 801 |
|